Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.

Sztanek, Ferenc; Seres, Ildikó; Harangi, Mariann; Locsey, Lajos; Padra, János; Paragh, György J R; Asztalos, László; Paragh, György

Sztanek, Ferenc; Seres, Ildikó; Harangi, Mariann; Locsey, Lajos; Padra, János; Paragh, György J R; Asztalos, László; Paragh, György.

Affiliation

Sztanek F; First Department of Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.

Nephrol Dial Transplant ; 27(7): 2866-72, 2012 Jul.

Article in En | MEDLINE | ID: mdl-22247228

Subject(s)

Aryldialkylphosphatase/blood; Biomarkers/blood; Cardiovascular Diseases/diagnosis; Cardiovascular Diseases/enzymology; Kidney Failure, Chronic/enzymology; Kidney Transplantation/adverse effects; Renal Dialysis/adverse effects; Cardiovascular Diseases/etiology; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic/complications; Kidney Failure, Chronic/therapy; Male; Middle Aged; Prognosis; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers / Cardiovascular Diseases / Renal Dialysis / Kidney Transplantation / Aryldialkylphosphatase / Kidney Failure, Chronic Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google